{"entity":{"id":"tj-biopharma","kind":"company","name":"TJ Biopharma","aka":["TJ Biopharma Co., Ltd."],"tldr":"TJ Biopharma is a Chinese developer in Shanghai that sponsors 2 registered cancer trials of Uliledlimab and Sintilimab.","summary":"TJ Biopharma appears on ClinicalTrials.gov as the industry sponsor of 2 interventional cancer trials (phase 2, 2/3), testing Uliledlimab, Sintilimab, Pemetrexed, Toripalimab in non small cell lung cancer. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov: trials sponsored by TJ Biopharma","url":"https://clinicaltrials.gov/search?spons=TJ%20Biopharma"}],"tags":["ctgov-sponsor","china","registry-only"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct07005336","nct06984588"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"Shanghai, China","country":"CN","companyType":"biotech","investors":[],"funding":[]},"route":"/companies/tj-biopharma/","neighbours":{"trial":[{"id":"nct07005336","kind":"trial","name":"A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untr","route":"/trials/nct07005336/"},{"id":"nct06984588","kind":"trial","name":"A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer","route":"/trials/nct06984588/"}]}}